IL102287A - Implant compositions containing a biologically continuous active protein peptide or polypeptide - Google Patents
Implant compositions containing a biologically continuous active protein peptide or polypeptideInfo
- Publication number
- IL102287A IL102287A IL10228792A IL10228792A IL102287A IL 102287 A IL102287 A IL 102287A IL 10228792 A IL10228792 A IL 10228792A IL 10228792 A IL10228792 A IL 10228792A IL 102287 A IL102287 A IL 102287A
- Authority
- IL
- Israel
- Prior art keywords
- polypeptide
- active protein
- biologically
- compositions containing
- implant compositions
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 239000007943 implant Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000036765 blood level Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/07—Stiffening bandages
- A61L15/10—Stiffening bandages containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Materials Engineering (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Prostheses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71989891A | 1991-06-24 | 1991-06-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL102287A0 IL102287A0 (en) | 1993-01-14 |
| IL102287A true IL102287A (en) | 2000-06-01 |
Family
ID=24891827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10228792A IL102287A (en) | 1991-06-24 | 1992-06-22 | Implant compositions containing a biologically continuous active protein peptide or polypeptide |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0523330B1 (enEXAMPLES) |
| JP (1) | JP3597205B2 (enEXAMPLES) |
| KR (1) | KR100221031B1 (enEXAMPLES) |
| CN (1) | CN1050301C (enEXAMPLES) |
| AT (1) | ATE135565T1 (enEXAMPLES) |
| AU (1) | AU656200B2 (enEXAMPLES) |
| BR (1) | BR9202374A (enEXAMPLES) |
| CA (1) | CA2071757C (enEXAMPLES) |
| DE (1) | DE69209173T2 (enEXAMPLES) |
| DK (1) | DK0523330T3 (enEXAMPLES) |
| ES (1) | ES2087337T3 (enEXAMPLES) |
| GE (1) | GEP19970992B (enEXAMPLES) |
| GR (1) | GR3019457T3 (enEXAMPLES) |
| HU (1) | HU217547B (enEXAMPLES) |
| IE (1) | IE74398B1 (enEXAMPLES) |
| IL (1) | IL102287A (enEXAMPLES) |
| LV (1) | LV11816B (enEXAMPLES) |
| MD (1) | MD1394G2 (enEXAMPLES) |
| MX (1) | MX9203175A (enEXAMPLES) |
| RU (1) | RU2080119C1 (enEXAMPLES) |
| SG (1) | SG47955A1 (enEXAMPLES) |
| TW (1) | TW215058B (enEXAMPLES) |
| UA (1) | UA26137C2 (enEXAMPLES) |
| ZA (1) | ZA924613B (enEXAMPLES) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| US8052982B2 (en) | 1998-07-20 | 2011-11-08 | Peptech Animal Health Pty Limited | Bioimplant formulation comprising lecithin and stearin |
| ES2389627T3 (es) * | 1998-07-20 | 2012-10-29 | Virbac (Australia) Pty Ltd | Formulación para bioimplantes |
| JP2001058955A (ja) * | 1999-06-17 | 2001-03-06 | Inst Of Physical & Chemical Res | 生理活性ペプチド徐放性製剤 |
| KR100890679B1 (ko) | 2000-02-24 | 2009-03-26 | 일라이 릴리 앤드 캄파니 | 소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들 |
| US6719992B2 (en) | 2000-06-26 | 2004-04-13 | Monsanto Technology Llc | Non-aqueous surfactant-containing formulations for extended release of somatotropin |
| US6664234B1 (en) | 2000-06-30 | 2003-12-16 | Monsanto Technology Llc | Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin |
| JP4931282B2 (ja) * | 2000-10-02 | 2012-05-16 | 日本ケミカルリサーチ株式会社 | 生理活性ペプチド含有粉末 |
| DE10161078A1 (de) * | 2001-12-12 | 2003-08-28 | Achim Goepferich | Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen |
| SE526959C2 (sv) * | 2003-10-02 | 2005-11-29 | Tikomed Ab | Bioartificellt implantat innefattande en semipermeabel barriär samt förfarande för reducering av risken för bildning av bindrväv vid implantatet efter implantering genom att barriären förses med en permeabel beläggning av bioaktiv metall |
| JP2005145821A (ja) * | 2003-11-11 | 2005-06-09 | Kao Corp | 打錠製剤 |
| JP2013515080A (ja) | 2009-12-21 | 2013-05-02 | アンブルックス，インコーポレイテッド | 修飾されているウシのソマトトロピンポリペプチドおよびそれらの使用 |
| PE20121799A1 (es) | 2009-12-21 | 2013-01-02 | Ambrx Inc | Polipeptidos de somatotropina porcina modificados y sus usos |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4271113A (en) * | 1978-04-17 | 1981-06-02 | Alza Corporation | Process for forming a passageway in an osmotic device |
| CA1257199A (en) * | 1986-05-20 | 1989-07-11 | Paul Y. Wang | Preparation containing bioactive macromolecular substance for multi-months release in vivo |
| US4863736A (en) * | 1987-03-16 | 1989-09-05 | Monsanto Company | Somatotropin prolonged release |
| US4795644A (en) * | 1987-08-03 | 1989-01-03 | Merck & Co., Inc. | Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins |
| HUT69680A (en) * | 1990-08-09 | 1995-09-28 | Endocon Inc | Implant and apparatus for delivering multiple drug and process for production of theese |
-
1992
- 1992-04-29 EP EP92107278A patent/EP0523330B1/en not_active Expired - Lifetime
- 1992-04-29 DK DK92107278.1T patent/DK0523330T3/da active
- 1992-04-29 AT AT92107278T patent/ATE135565T1/de not_active IP Right Cessation
- 1992-04-29 SG SG1996005631A patent/SG47955A1/en unknown
- 1992-04-29 ES ES92107278T patent/ES2087337T3/es not_active Expired - Lifetime
- 1992-04-29 DE DE69209173T patent/DE69209173T2/de not_active Expired - Fee Related
- 1992-05-04 TW TW081103470A patent/TW215058B/zh active
- 1992-06-19 JP JP18465792A patent/JP3597205B2/ja not_active Expired - Fee Related
- 1992-06-22 IL IL10228792A patent/IL102287A/xx not_active IP Right Cessation
- 1992-06-22 CA CA002071757A patent/CA2071757C/en not_active Expired - Fee Related
- 1992-06-23 HU HU9202092A patent/HU217547B/hu not_active IP Right Cessation
- 1992-06-23 RU SU925052163A patent/RU2080119C1/ru not_active IP Right Cessation
- 1992-06-23 AU AU18470/92A patent/AU656200B2/en not_active Ceased
- 1992-06-23 KR KR1019920010911A patent/KR100221031B1/ko not_active Expired - Fee Related
- 1992-06-23 CN CN92105065A patent/CN1050301C/zh not_active Expired - Fee Related
- 1992-06-23 ZA ZA924613A patent/ZA924613B/xx unknown
- 1992-06-23 MX MX9203175A patent/MX9203175A/es not_active IP Right Cessation
- 1992-06-23 BR BR929202374A patent/BR9202374A/pt not_active Application Discontinuation
- 1992-07-01 IE IE922020A patent/IE74398B1/en not_active IP Right Cessation
-
1993
- 1993-06-15 UA UA93002879A patent/UA26137C2/uk unknown
- 1993-07-31 GE GEAP19931351A patent/GEP19970992B/en unknown
-
1994
- 1994-07-12 MD MD94-0370A patent/MD1394G2/ro unknown
-
1996
- 1996-03-29 GR GR950403216T patent/GR3019457T3/el unknown
-
1997
- 1997-03-05 LV LVP-97-37A patent/LV11816B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ227787A (en) | Peptides and compositions having growth hormone regulatory effects | |
| EP0212474A3 (en) | Bone morphogenetic peptides | |
| FI101938B1 (fi) | Polypeptidijohdannaisia | |
| GR3019457T3 (en) | Implant compositions containing a biologically active protein, peptide or polypeptide | |
| ZA941771B (en) | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof | |
| GR3030382T3 (en) | Cytokine restraining agents. | |
| NZ512083A (en) | Methods of increasing lean tissue mass using OB protein compositions | |
| EP0162813A3 (en) | Pharmaceutical compositions containing a dipeptide | |
| ZA942729B (en) | Modified protein and peptide pharmaceuticals. | |
| EP0383837A4 (en) | Alveolar surfactant proteins | |
| GR3031927T3 (en) | Cysteine depleted il-6 muteins | |
| ATE225806T1 (de) | D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet | |
| DE69434997D1 (de) | Menschliches Chondromodulin-I-Protein | |
| ATE93527T1 (de) | Peptide und deren benutzung. | |
| EP0490383A3 (en) | Peptides of the hiv-gag protein, their preparation and use | |
| NZ220325A (en) | Implants containing peptide or protein medicament in permeable polymeric coating | |
| EP0723016A3 (en) | Leukocyte activation factor | |
| MX9604539A (es) | Aminoacidos modificados para la distribucion de farmaco. | |
| EP0446100A3 (en) | Method for the quantitative determination of the biologically active form of the human nerve growth factor in protein liquids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |